DADM: The first 2 years of the Alzheimer Association's open access journal to support the research and development of novel biomarkers and diagnostic approaches

DADM: The first 2 years of the Alzheimer Association's open access journal to support the research and development of novel biomarkers and diagnostic approaches:

Dementia Big
In March 2015, after several years of planning by the Alzheimer's Association, its main scientific journal Alzheimer’s & Dementia, and the journal’s publisher, the association launched its first online open access journal, Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring [1] (http://ift.tt/292dqp3). Going by the acronym “DADM,” this journal was conceived of as an important new vehicle to advance the discovery, development, and validation of much-needed biomarkers to refine the ability to diagnose the disease in its earliest stages, or to sensitively track disease progression [2].

http://ift.tt/298GA8f